Can a blood pressure drug protect kidneys in scleroderma crisis?
NCT ID NCT01241383
First seen May 12, 2026 · Last updated Jun 13, 2026 · Updated 5 times
Summary
This study tested whether bosentan, a drug used for lung and blood vessel problems, can help protect kidney function in people with scleroderma who develop a sudden kidney crisis. Sixteen adults with scleroderma and kidney crisis took bosentan for 6 months. The goal was to see if the drug could improve kidney outcomes and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA RENAL CRISIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pôle de médecine interne Centre de référence Maladies rares Groupe I Maladies systémiques et maladies auto-immunes rares en particulier Vascularites nécrosantes et les sclérodermies - Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.